82 related articles for article (PubMed ID: 367975)
1. Pirbuterol in the treatment of bronchial asthma.
Beumer HM
Int J Clin Pharmacol Biopharm; 1979 Jan; 17(1):18-25. PubMed ID: 367975
[TBL] [Abstract][Full Text] [Related]
2. Comparative investigations on pirbuterol, salbutamol and placebo aerosols in bronchial asthma.
Beumer HM
Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):237-9. PubMed ID: 381220
[TBL] [Abstract][Full Text] [Related]
3. Acute bronchial and cardiovascular effects of increasing doses of pirbuterol acetate aerosol in asthma.
Littner MR; Tashkin DP; Calvarese B; Bautista M
Ann Allergy; 1982 Jan; 48(1):14-20. PubMed ID: 7055342
[No Abstract] [Full Text] [Related]
4. Long-term treatment of bronchial asthma with pirbuterol aerosol.
Beumer HM
Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):172-5. PubMed ID: 6862719
[TBL] [Abstract][Full Text] [Related]
5. Pirbuterol versus orciprenaline aerosols in the treatment of bronchial asthma.
Beumer HM
Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):147-66. PubMed ID: 6343262
[TBL] [Abstract][Full Text] [Related]
6. Fenoterol: clinical trial of a new long acting bronchodilator.
Emirgil C; Palmer K; VanVoorhies L; Wesson C; Sobol BJ
Ann Allergy; 1977 Dec; 39(6):415-7. PubMed ID: 339786
[TBL] [Abstract][Full Text] [Related]
7. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol.
Ence TJ; Tashkin DP; Ho D; Child JS
Ann Allergy; 1979 Oct; 43(4):229-36. PubMed ID: 555600
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, crossover comparison of carbuterol and salbutamol.
Guleria JS; Vasu KV; Pande JN
Ann Allergy; 1979 Aug; 43(2):123-5. PubMed ID: 380412
[TBL] [Abstract][Full Text] [Related]
9. Pyrbuterol: a new bronchodilator. Phase I-single dose study.
Steen SN; Ziment I; Thomas JS
Curr Ther Res Clin Exp; 1974 Oct; 16(10):1077-81. PubMed ID: 4215618
[No Abstract] [Full Text] [Related]
10. Pirbuterol vs. hydroxyzine vs. theophylline vs. placebo in the treatment of bronchial asthma.
Brandon ML
Ann Allergy; 1980 Jul; 45(1):8-12. PubMed ID: 7406244
[TBL] [Abstract][Full Text] [Related]
11. Long-term oral bronchodilator therapy of asthma with pirbuterol.
Burki NK; Diamond L
Clin Pharmacol Ther; 1978 Jul; 24(1):84-9. PubMed ID: 657723
[TBL] [Abstract][Full Text] [Related]
12. A clinical comparison of subcutaneous doses of Terbutaline and adrenaline in bronchial asthma.
Nõu E
Scand J Respir Dis; 1971; 52(4):192-8. PubMed ID: 4949816
[No Abstract] [Full Text] [Related]
13. [Bronchodilator effect of hexoprenalin administered in a dosed aerosol form (spirographic evaluation)].
Cornudella R; Castellano A; Santafé G
Rev Clin Esp; 1973 Jun; 129(5):469-76. PubMed ID: 4732991
[No Abstract] [Full Text] [Related]
14. Bronchodilator combinations in animals and in man.
Mattila MJ; Salonen RO; Ruotsalainen EM
Ann Clin Res; 1985; 17(3):120-2. PubMed ID: 3901875
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral terbutaline in asthmatic patients. A dose response study.
Fagerberg E; Tegner KB
Scand J Respir Dis; 1972; 53(1):3-9. PubMed ID: 4559526
[No Abstract] [Full Text] [Related]
16. Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol.
Tinkelman DG; Brandon ML; Grieco M; Hudson L; Rosenthal RR; Spector SL; Tashkin D; Votteri B
Ann Allergy; 1990 Feb; 64(2 Pt 2):202-6. PubMed ID: 2405746
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
Mazza JA; Tashkin DP; Reed CE
Ann Allergy; 1992 Mar; 68(3):267-73. PubMed ID: 1532117
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new B 2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. II. Oral comparison with ephedrine.
Dulfano MJ; Glass P
Curr Ther Res Clin Exp; 1973 Apr; 15(4):150-7. PubMed ID: 4144567
[No Abstract] [Full Text] [Related]
19. Comparison of pirbuterol and pirbuterol and hydroxyzine in patients with reversible airway obstruction.
Poppius H; Lehti H; Stenius-Aarniala B
Eur J Clin Pharmacol; 1979 Jul; 15(6):389-93. PubMed ID: 387417
[TBL] [Abstract][Full Text] [Related]
20. Effect of increasing dosage of an inhaled beta-2 specific agonist on pulmonary function, tremor, and cardiovascular indices.
Tinkelman DG; Lutz C
Ann Allergy; 1992 Jan; 68(1):23-6. PubMed ID: 1346562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
